Implantable Microelectrodes for Deep Brain Stimulation.
Aleva Neurotherapeutics SA
Incorporated
14.07.2008Headquarters
LausanneSupport
Implantable Microelectrodes for Deep Brain Stimulation. Aleva Neurotherapeutics has developed a proprietary technology that enables significantly better therapies for a broad range of neurological diseases.
Awards
News
CE-Mark for Aleva’s Deep Brain Stimulation (startupticker.ch)
Sparks IPO Academy completes first edition with 13 companies (startupticker.ch)
Aleva receives FDA approval to start US Study (startupticker.ch)
Aleva’s first Deep Brain Stimulation System implanted (startupticker.ch)
Three companies a step away from winning the Swiss Medtech Award (startupticker.ch)
Swiss Medtech Award presents the shortlist (startupticker.ch)
Aleva Neurotherapeutics Raises USD 8M and Gets CE Mark Certification (venturelab.swiss)
Aleva secures a CE mark and $8 million (startupticker.ch)
Aleva Neurotherapeutics forms joint venture with DIXI Medical (startupticker.ch)
New hires to foster the next steps of development (startupticker.ch)
Aleva Neurotherapeutics raises USD 13 Million in Series D round (startupticker.ch)
Aleva Neurotherapeutics raises USD 13 Million in Series D round (startupticker.ch)
Aleva Neurotherapeutics Raises USD 18 Million in Series C Financing Round (startupticker.ch)
New partner and investor for Aleva Neurotherapeutics (startupticker.ch)
Aleva Neurotherapeutics awarded Grant from The Michael J. Fox Foundation (startupticker.ch)
Aleva Neurotherapeutics appoints former Glycovaxyn CEO to its Board of Directors (startupticker.ch)
Study confirms proof-of-concept for innovative DBS lead developed by Aleva Neurotherapeutics (startupticker.ch)
Aleva Neurotherapeutics Announces Promising Clinical Data (startupticker.ch)
Aleva Neurotherapeutics Raises CHF 4.0 Million in Series B Financing Round (startupticker.ch)
Aleva Neurotherapeutics Closes EUR 9.5 Million Series A Financing Round (startupticker.ch)